Status:
COMPLETED
Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
To assess posterior capsule opacification (PCO) in patients implanted with either the AcrySof SN60AT lens or the AcrySof SN60WF lens.
Eligibility Criteria
Inclusion
- patients with bilateral senile cataracts
- Age \> 50 years
- Fit for hospital follow ups
- Pupils dilating \> 6mm preoperatively
- Eyes expected to see 6/12 or better postoperatively
Exclusion
- Diabetes
- On treatment for glaucoma
- Other ocular pathology
- Previous ocular surgery
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00762021
Start Date
December 1 2006
Last Update
December 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134